| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.933 | Human |
| meiotic chromosome segregation | GO:0045132 | 59 | 0.911 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 240 | 0.911 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.883 | |
| nuclear division | GO:0000280 | 332 | 0.845 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.833 | Human |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.833 | Human |
| negative regulation of gene expression epigenetic | GO:0045814 | 77 | 0.826 | |
| gene silencing | GO:0016458 | 138 | 0.824 | |
| meiotic nuclear division | GO:0007126 | 151 | 0.803 | |
| regulation of chromatin silencing | GO:0031935 | 36 | 0.787 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.779 | |
| response to other organism | GO:0051707 | 293 | 0.758 | |
| regulation of chromosome organization | GO:0033044 | 64 | 0.690 | Human |
| negative regulation of gene expression | GO:0010629 | 387 | 0.665 | |
| tube development | GO:0035295 | 244 | 0.664 | |
| meiotic cell cycle process | GO:1903046 | 132 | 0.658 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.637 | Human |
| spindle organization | GO:0007051 | 253 | 0.624 | |
| chromosome organization | GO:0051276 | 360 | 0.615 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 267 | 0.602 | Human |
| dendrite morphogenesis | GO:0048813 | 199 | 0.573 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.555 | |
| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.551 | |
| covalent chromatin modification | GO:0016569 | 106 | 0.499 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.490 | |
| chromatin modification | GO:0016568 | 147 | 0.452 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.449 | |
| reproductive structure development | GO:0048608 | 74 | 0.447 | |
| central nervous system development | GO:0007417 | 201 | 0.436 | |
| regulation of organelle organization | GO:0033043 | 196 | 0.425 | Human |
| positive regulation of cellular component organization | GO:0051130 | 156 | 0.414 | |
| histone acetylation | GO:0016573 | 38 | 0.408 | |
| histone modification | GO:0016570 | 106 | 0.394 | |
| morphogenesis of an epithelium | GO:0002009 | 276 | 0.384 | |
| regulation of cellular protein metabolic process | GO:0032268 | 243 | 0.378 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.364 | Worm |
| muscle structure development | GO:0061061 | 224 | 0.361 | |
| tissue morphogenesis | GO:0048729 | 297 | 0.348 | |
| establishment of localization in cell | GO:0051649 | 402 | 0.333 | |
| cellular response to dna damage stimulus | GO:0006974 | 223 | 0.321 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.314 | |
| organelle assembly | GO:0070925 | 198 | 0.312 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.311 | |
| mating | GO:0007618 | 120 | 0.309 | |
| mitotic cell cycle checkpoint | GO:0007093 | 88 | 0.297 | |
| purine nucleotide catabolic process | GO:0006195 | 109 | 0.294 | |
| regulation of protein metabolic process | GO:0051246 | 256 | 0.293 | |
| dna metabolic process | GO:0006259 | 227 | 0.278 | Human |
| multi organism behavior | GO:0051705 | 175 | 0.270 | Worm |
| ribonucleotide metabolic process | GO:0009259 | 145 | 0.267 | |
| multicellular organismal reproductive behavior | GO:0033057 | 110 | 0.265 | Worm |
| mitotic dna damage checkpoint | GO:0044773 | 74 | 0.265 | |
| peptidyl lysine modification | GO:0018205 | 57 | 0.259 | |
| imaginal disc derived appendage development | GO:0048737 | 399 | 0.258 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.252 | |
| dendrite development | GO:0016358 | 204 | 0.244 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 265 | 0.241 | Human |
| protein modification by small protein conjugation or removal | GO:0070647 | 106 | 0.239 | |
| chromatin silencing | GO:0006342 | 76 | 0.230 | |
| sensory organ morphogenesis | GO:0090596 | 260 | 0.228 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.219 | |
| organelle fission | GO:0048285 | 340 | 0.219 | |
| embryonic morphogenesis | GO:0048598 | 206 | 0.218 | |
| protein acetylation | GO:0006473 | 39 | 0.209 | |
| response to external biotic stimulus | GO:0043207 | 293 | 0.201 | |
| epithelial cell differentiation | GO:0030855 | 322 | 0.201 | |
| cell migration | GO:0016477 | 238 | 0.198 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 266 | 0.196 | |
| sex differentiation | GO:0007548 | 81 | 0.191 | |
| negative regulation of cellular component organization | GO:0051129 | 108 | 0.190 | Human |
| chromatin organization | GO:0006325 | 207 | 0.187 | |
| positive regulation of organelle organization | GO:0010638 | 65 | 0.183 | |
| compound eye photoreceptor cell differentiation | GO:0001751 | 140 | 0.183 | |
| cellular protein modification process | GO:0006464 | 438 | 0.182 | |
| dna damage checkpoint | GO:0000077 | 78 | 0.182 | |
| regulation of gene expression epigenetic | GO:0040029 | 128 | 0.178 | |
| internal protein amino acid acetylation | GO:0006475 | 38 | 0.178 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 120 | 0.172 | |
| regulation of molecular function | GO:0065009 | 217 | 0.168 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 109 | 0.167 | |
| protein complex assembly | GO:0006461 | 200 | 0.165 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 277 | 0.164 | Human |
| regulation of catalytic activity | GO:0050790 | 185 | 0.156 | |
| response to biotic stimulus | GO:0009607 | 294 | 0.152 | |
| nucleotide catabolic process | GO:0009166 | 109 | 0.149 | |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.149 | |
| epithelial cell development | GO:0002064 | 274 | 0.147 | |
| chromosome segregation | GO:0007059 | 157 | 0.147 | |
| purine nucleotide metabolic process | GO:0006163 | 146 | 0.143 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 249 | 0.142 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.142 | |
| regulation of immune system process | GO:0002682 | 176 | 0.138 | |
| peptidyl lysine acetylation | GO:0018394 | 39 | 0.137 | |
| localization of cell | GO:0051674 | 257 | 0.135 | |
| establishment or maintenance of cell polarity | GO:0007163 | 167 | 0.132 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.132 | |
| macromolecular complex assembly | GO:0065003 | 256 | 0.132 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.131 | |
| immune system process | GO:0002376 | 347 | 0.130 | |
| neuron projection guidance | GO:0097485 | 241 | 0.129 | |
| internal peptidyl lysine acetylation | GO:0018393 | 38 | 0.128 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.124 | |
| cell division | GO:0051301 | 248 | 0.121 | |
| compound eye photoreceptor development | GO:0042051 | 78 | 0.117 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 108 | 0.117 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.117 | Human |
| dna integrity checkpoint | GO:0031570 | 81 | 0.117 | |
| negative regulation of response to stimulus | GO:0048585 | 258 | 0.115 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.114 | |
| immune response | GO:0006955 | 246 | 0.112 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 242 | 0.111 | |
| establishment of protein localization | GO:0045184 | 163 | 0.111 | |
| protein transport | GO:0015031 | 155 | 0.109 | |
| regulation of gene silencing | GO:0060968 | 63 | 0.109 | |
| negative regulation of transcription dna templated | GO:0045892 | 237 | 0.108 | |
| cellular catabolic process | GO:0044248 | 372 | 0.107 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 50 | 0.103 | |
| mitotic spindle organization | GO:0007052 | 220 | 0.102 | |
| leg disc development | GO:0035218 | 92 | 0.102 | |
| nucleotide metabolic process | GO:0009117 | 161 | 0.102 | |
| negative regulation of biosynthetic process | GO:0009890 | 277 | 0.101 | Human |
| eye photoreceptor cell development | GO:0042462 | 81 | 0.100 | |
| purine ribonucleoside metabolic process | GO:0046128 | 127 | 0.098 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 119 | 0.098 | |
| female meiosis chromosome segregation | GO:0016321 | 33 | 0.098 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.096 | |
| blastoderm segmentation | GO:0007350 | 159 | 0.095 | |
| defense response | GO:0006952 | 300 | 0.094 | |
| regulation of protein modification process | GO:0031399 | 112 | 0.092 | |
| cell motility | GO:0048870 | 251 | 0.091 | |
| imaginal disc derived wing morphogenesis | GO:0007476 | 337 | 0.090 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 0 | 0.089 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 256 | 0.087 | |
| protein modification process | GO:0036211 | 438 | 0.086 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.085 | |
| single organism catabolic process | GO:0044712 | 228 | 0.084 | |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.083 | |
| purine containing compound metabolic process | GO:0072521 | 155 | 0.081 | |
| regulation of immune response | GO:0050776 | 118 | 0.081 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.078 | |
| defense response to other organism | GO:0098542 | 225 | 0.078 | |
| multi multicellular organism process | GO:0044706 | 123 | 0.078 | Worm |
| imaginal disc derived appendage morphogenesis | GO:0035114 | 395 | 0.077 | |
| purine nucleoside metabolic process | GO:0042278 | 127 | 0.077 | |
| carbohydrate derivative metabolic process | GO:1901135 | 217 | 0.077 | |
| establishment of planar polarity | GO:0001736 | 87 | 0.077 | |
| regulation of hydrolase activity | GO:0051336 | 97 | 0.076 | |
| cell fate specification | GO:0001708 | 71 | 0.073 | |
| protein maturation | GO:0051604 | 71 | 0.072 | |
| positive regulation of hydrolase activity | GO:0051345 | 78 | 0.069 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 3 | 0.068 | |
| regulation of cellular amine metabolic process | GO:0033238 | 3 | 0.068 | |
| male mating behavior | GO:0060179 | 70 | 0.067 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.067 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.067 | |
| axon development | GO:0061564 | 297 | 0.067 | |
| single organism cellular localization | GO:1902580 | 180 | 0.064 | Human |
| regulation of chromatin modification | GO:1903308 | 28 | 0.064 | |
| dna repair | GO:0006281 | 54 | 0.063 | |
| anterior posterior pattern specification | GO:0009952 | 136 | 0.062 | |
| embryonic pattern specification | GO:0009880 | 174 | 0.062 | |
| positive regulation of chromatin silencing | GO:0031937 | 16 | 0.061 | |
| chorion containing eggshell formation | GO:0007304 | 105 | 0.060 | |
| organophosphate metabolic process | GO:0019637 | 195 | 0.059 | |
| regulation of cell proliferation | GO:0042127 | 163 | 0.059 | |
| eye morphogenesis | GO:0048592 | 260 | 0.058 | |
| female meiotic division | GO:0007143 | 70 | 0.058 | |
| larval development | GO:0002164 | 104 | 0.058 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.057 | |
| regulation of cell shape | GO:0008360 | 113 | 0.057 | |
| head development | GO:0060322 | 135 | 0.057 | |
| intracellular transport | GO:0046907 | 228 | 0.057 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 108 | 0.056 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.055 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 119 | 0.054 | |
| brain development | GO:0007420 | 120 | 0.053 | |
| response to alcohol | GO:0097305 | 95 | 0.053 | |
| eye photoreceptor cell differentiation | GO:0001754 | 145 | 0.052 | |
| positive regulation of molecular function | GO:0044093 | 136 | 0.052 | |
| histone h3 k9 acetylation | GO:0043970 | 3 | 0.052 | |
| macromolecule catabolic process | GO:0009057 | 161 | 0.051 | |
| amine metabolic process | GO:0009308 | 12 | 0.051 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.050 | |
| neurological system process | GO:0050877 | 358 | 0.050 | |
| protein localization | GO:0008104 | 284 | 0.050 | Human |
| body morphogenesis | GO:0010171 | 2 | 0.050 | |
| compound eye morphogenesis | GO:0001745 | 249 | 0.050 | |
| digestive system development | GO:0055123 | 149 | 0.049 | |
| chromatin remodeling | GO:0006338 | 72 | 0.049 | |
| cuticle development | GO:0042335 | 86 | 0.048 | |
| defense response to bacterium | GO:0042742 | 178 | 0.048 | |
| cellular ketone metabolic process | GO:0042180 | 24 | 0.048 | |
| regulation of proteolysis | GO:0030162 | 87 | 0.048 | |
| death | GO:0016265 | 284 | 0.048 | |
| negative regulation of signal transduction | GO:0009968 | 206 | 0.048 | |
| regulation of organ morphogenesis | GO:2000027 | 78 | 0.048 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 34 | 0.047 | |
| regulation of cell death | GO:0010941 | 173 | 0.047 | |
| protein modification by small protein removal | GO:0070646 | 28 | 0.047 | |
| purine nucleoside catabolic process | GO:0006152 | 112 | 0.047 | |
| ribonucleoside metabolic process | GO:0009119 | 127 | 0.046 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 93 | 0.046 | |
| cellular macromolecule localization | GO:0070727 | 220 | 0.045 | Human |
| mitotic g2 dna damage checkpoint | GO:0007095 | 69 | 0.045 | |
| glycosyl compound catabolic process | GO:1901658 | 112 | 0.044 | |
| protein deacetylation | GO:0006476 | 9 | 0.044 | |
| photoreceptor cell differentiation | GO:0046530 | 170 | 0.043 | |
| negative regulation of organelle organization | GO:0010639 | 56 | 0.043 | Human |
| actin cytoskeleton organization | GO:0030036 | 206 | 0.043 | |
| eye development | GO:0001654 | 323 | 0.043 | |
| meiosis i | GO:0007127 | 59 | 0.043 | |
| protein complex biogenesis | GO:0070271 | 201 | 0.042 | |
| positive regulation of catalytic activity | GO:0043085 | 118 | 0.042 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.042 | |
| appendage development | GO:0048736 | 401 | 0.042 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 119 | 0.042 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 85 | 0.041 | |
| development of primary sexual characteristics | GO:0045137 | 50 | 0.041 | |
| nucleoside catabolic process | GO:0009164 | 112 | 0.041 | |
| protein acylation | GO:0043543 | 42 | 0.041 | |
| regionalization | GO:0003002 | 416 | 0.041 | |
| regulation of meiosis | GO:0040020 | 3 | 0.040 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 7 | 0.040 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 93 | 0.040 | |
| reproductive system development | GO:0061458 | 74 | 0.040 | |
| negative regulation of cell communication | GO:0010648 | 223 | 0.039 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 108 | 0.039 | |
| dna methylation | GO:0006306 | 4 | 0.039 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 55 | 0.039 | |
| embryonic development via the syncytial blastoderm | GO:0001700 | 148 | 0.038 | |
| ras protein signal transduction | GO:0007265 | 88 | 0.037 | |
| vesicle mediated transport | GO:0016192 | 381 | 0.037 | |
| organic substance transport | GO:0071702 | 257 | 0.037 | |
| glycosyl compound metabolic process | GO:1901657 | 127 | 0.037 | |
| nucleoside metabolic process | GO:0009116 | 127 | 0.037 | |
| nucleoside phosphate metabolic process | GO:0006753 | 162 | 0.037 | |
| positive regulation of cellular protein metabolic process | GO:0032270 | 118 | 0.036 | |
| axon guidance | GO:0007411 | 233 | 0.036 | |
| neuron recognition | GO:0008038 | 101 | 0.036 | |
| positive regulation of transferase activity | GO:0051347 | 26 | 0.036 | |
| single organism intracellular transport | GO:1902582 | 207 | 0.035 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.035 | |
| gonad development | GO:0008406 | 50 | 0.035 | |
| negative regulation of cell cycle | GO:0045786 | 116 | 0.035 | Human |
| cellular protein localization | GO:0034613 | 160 | 0.034 | Human |
| compound eye development | GO:0048749 | 307 | 0.034 | |
| gtp metabolic process | GO:0046039 | 72 | 0.034 | |
| antimicrobial humoral response | GO:0019730 | 99 | 0.034 | |
| response to ecdysone | GO:0035075 | 34 | 0.033 | |
| purine ribonucleoside catabolic process | GO:0046130 | 112 | 0.033 | |
| small gtpase mediated signal transduction | GO:0007264 | 88 | 0.033 | |
| positive regulation of response to stimulus | GO:0048584 | 323 | 0.033 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.033 | |
| meiotic chromosome condensation | GO:0010032 | 3 | 0.033 | |
| regulation of cell development | GO:0060284 | 215 | 0.032 | |
| limb development | GO:0060173 | 1 | 0.032 | |
| endocytosis | GO:0006897 | 310 | 0.032 | |
| protein dna complex subunit organization | GO:0071824 | 86 | 0.032 | |
| developmental programmed cell death | GO:0010623 | 138 | 0.031 | |
| intracellular receptor signaling pathway | GO:0030522 | 19 | 0.031 | |
| nuclear transport | GO:0051169 | 72 | 0.031 | |
| regulation of chromatin organization | GO:1902275 | 32 | 0.031 | |
| appendage morphogenesis | GO:0035107 | 397 | 0.031 | |
| growth | GO:0040007 | 359 | 0.031 | |
| leg disc morphogenesis | GO:0007478 | 80 | 0.030 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 108 | 0.029 | |
| negative regulation of signaling | GO:0023057 | 219 | 0.029 | |
| renal system development | GO:0072001 | 72 | 0.028 | |
| embryonic organ development | GO:0048568 | 50 | 0.028 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.028 | |
| positive regulation of protein metabolic process | GO:0051247 | 128 | 0.027 | |
| ribose phosphate metabolic process | GO:0019693 | 145 | 0.027 | |
| positive regulation of protein modification process | GO:0031401 | 58 | 0.027 | |
| cellular amino acid metabolic process | GO:0006520 | 61 | 0.027 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.027 | |
| regulation of ras protein signal transduction | GO:0046578 | 93 | 0.026 | |
| intracellular signal transduction | GO:0035556 | 300 | 0.026 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 119 | 0.026 | |
| single organism membrane organization | GO:0044802 | 93 | 0.025 | |
| dna conformation change | GO:0071103 | 105 | 0.025 | |
| g2 dna damage checkpoint | GO:0031572 | 69 | 0.024 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.024 | |
| nucleobase containing compound catabolic process | GO:0034655 | 165 | 0.024 | |
| organophosphate catabolic process | GO:0046434 | 112 | 0.024 | |
| mitotic dna integrity checkpoint | GO:0044774 | 75 | 0.024 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 139 | 0.024 | |
| cytoskeleton dependent cytokinesis | GO:0061640 | 81 | 0.023 | |
| regulation of response to gamma radiation | GO:2001228 | 4 | 0.023 | |
| response to organic substance | GO:0010033 | 284 | 0.023 | |
| axis specification | GO:0009798 | 167 | 0.023 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 0 | 0.023 | |
| regulation of intracellular protein transport | GO:0033157 | 46 | 0.023 | |
| regulation of cellular catabolic process | GO:0031329 | 157 | 0.023 | |
| regulation of transferase activity | GO:0051338 | 58 | 0.022 | |
| negative regulation of chromosome organization | GO:2001251 | 19 | 0.022 | Human |
| reproductive behavior | GO:0019098 | 122 | 0.022 | Worm |
| protein targeting | GO:0006605 | 64 | 0.022 | |
| purine containing compound catabolic process | GO:0072523 | 112 | 0.022 | |
| establishment of protein localization to organelle | GO:0072594 | 62 | 0.022 | |
| regulation of apoptotic process | GO:0042981 | 130 | 0.022 | |
| mitotic cell cycle embryonic | GO:0045448 | 38 | 0.022 | |
| nucleocytoplasmic transport | GO:0006913 | 72 | 0.021 | |
| positive regulation of proteolysis | GO:0045862 | 52 | 0.021 | |
| dna methylation or demethylation | GO:0044728 | 4 | 0.021 | |
| regulation of compound eye cone cell fate specification | GO:0042682 | 4 | 0.021 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.021 | |
| regulation of hemocyte proliferation | GO:0035206 | 37 | 0.021 | |
| negative regulation of neurogenesis | GO:0050768 | 53 | 0.021 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 80 | 0.020 | |
| regulation of microtubule based process | GO:0032886 | 49 | 0.020 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 57 | 0.020 | |
| regulation of protein transport | GO:0051223 | 57 | 0.020 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.020 | |
| negative regulation of catalytic activity | GO:0043086 | 42 | 0.020 | |
| regulation of protein phosphorylation | GO:0001932 | 64 | 0.020 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.020 | |
| nucleoside phosphate catabolic process | GO:1901292 | 110 | 0.020 | |
| regulation of cell fate specification | GO:0042659 | 27 | 0.020 | |
| regulation of transport | GO:0051049 | 181 | 0.019 | |
| r3 r4 cell differentiation | GO:0048056 | 12 | 0.019 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.019 | |
| dna alkylation | GO:0006305 | 4 | 0.019 | |
| hemopoiesis | GO:0030097 | 46 | 0.019 | |
| axon choice point recognition | GO:0016198 | 26 | 0.019 | |
| homeostatic process | GO:0042592 | 199 | 0.019 | |
| regulation of cell fate commitment | GO:0010453 | 29 | 0.019 | |
| cellular macromolecule catabolic process | GO:0044265 | 136 | 0.019 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 62 | 0.019 | |
| digestive tract development | GO:0048565 | 149 | 0.018 | |
| regulation of neurogenesis | GO:0050767 | 158 | 0.018 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 51 | 0.018 | |
| regulation of protein import into nucleus | GO:0042306 | 28 | 0.018 | |
| regulation of neuron differentiation | GO:0045664 | 103 | 0.018 | |
| response to sterol | GO:0036314 | 34 | 0.018 | |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.018 | |
| post embryonic appendage morphogenesis | GO:0035120 | 385 | 0.017 | |
| jnk cascade | GO:0007254 | 50 | 0.017 | |
| regulation of programmed cell death | GO:0043067 | 152 | 0.017 | |
| response to ketone | GO:1901654 | 34 | 0.017 | |
| protein processing | GO:0016485 | 68 | 0.017 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 48 | 0.017 | |
| tube morphogenesis | GO:0035239 | 191 | 0.017 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 151 | 0.017 | |
| mitotic g2 m transition checkpoint | GO:0044818 | 70 | 0.017 | |
| negative regulation of multicellular organismal process | GO:0051241 | 142 | 0.017 | |
| nucleosome mobilization | GO:0042766 | 9 | 0.016 | |
| striated muscle cell development | GO:0055002 | 50 | 0.016 | |
| regulation of embryonic development | GO:0045995 | 68 | 0.016 | |
| cell proliferation | GO:0008283 | 299 | 0.016 | |
| digestive tract morphogenesis | GO:0048546 | 127 | 0.016 | |
| intracellular protein transport | GO:0006886 | 104 | 0.016 | |
| regulation of response to stress | GO:0080134 | 200 | 0.016 | |
| regulation of histone modification | GO:0031056 | 20 | 0.016 | |
| cellular response to organic substance | GO:0071310 | 132 | 0.016 | |
| regulation of multicellular organismal development | GO:2000026 | 414 | 0.016 | |
| histone h3 k27 methylation | GO:0070734 | 6 | 0.016 | |
| cellular response to endogenous stimulus | GO:0071495 | 80 | 0.016 | |
| regulation of cellular response to stress | GO:0080135 | 89 | 0.016 | |
| multi organism reproductive behavior | GO:0044705 | 121 | 0.016 | Worm |
| tissue migration | GO:0090130 | 155 | 0.016 | |
| negative regulation of proteolysis | GO:0045861 | 31 | 0.015 | |
| positive regulation of catabolic process | GO:0009896 | 105 | 0.015 | |
| sister chromatid segregation | GO:0000819 | 92 | 0.015 | |
| protein modification by small protein conjugation | GO:0032446 | 79 | 0.015 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 45 | 0.015 | |
| actin filament based process | GO:0030029 | 220 | 0.015 | |
| atp metabolic process | GO:0046034 | 49 | 0.015 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.015 | |
| humoral immune response | GO:0006959 | 117 | 0.015 | |
| organonitrogen compound catabolic process | GO:1901565 | 128 | 0.015 | |
| regulation of protein targeting | GO:1903533 | 29 | 0.015 | |
| regulation of ras gtpase activity | GO:0032318 | 38 | 0.014 | |
| compound eye retinal cell programmed cell death | GO:0046667 | 23 | 0.014 | |
| negative regulation of protein metabolic process | GO:0051248 | 85 | 0.014 | |
| photoreceptor cell development | GO:0042461 | 96 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 71 | 0.014 | |
| epithelial tube morphogenesis | GO:0060562 | 88 | 0.014 | |
| compound eye photoreceptor fate commitment | GO:0001752 | 36 | 0.014 | |
| regulation of phosphatase activity | GO:0010921 | 3 | 0.014 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 37 | 0.014 | |
| segmentation | GO:0035282 | 207 | 0.014 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 50 | 0.014 | |
| pupal development | GO:0035209 | 11 | 0.013 | |
| dna packaging | GO:0006323 | 91 | 0.013 | |
| catabolic process | GO:0009056 | 409 | 0.013 | |
| regulation of embryonic cell shape | GO:0016476 | 30 | 0.013 | |
| regulation of localization | GO:0032879 | 275 | 0.013 | Human |
| regulation of intracellular transport | GO:0032386 | 64 | 0.013 | |
| histone h4 k16 acetylation | GO:0043984 | 4 | 0.013 | |
| camera type eye development | GO:0043010 | 4 | 0.013 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 35 | 0.013 | |
| locomotory behavior | GO:0007626 | 176 | 0.013 | |
| proteolysis | GO:0006508 | 192 | 0.012 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 174 | 0.012 | |
| regulation of retinal cell programmed cell death | GO:0046668 | 18 | 0.012 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 20 | 0.012 | |
| maternal determination of dorsal ventral axis ovarian follicular epithelium germ line encoded | GO:0008070 | 2 | 0.012 | |
| guanosine containing compound metabolic process | GO:1901068 | 74 | 0.012 | |
| positive regulation of immune system process | GO:0002684 | 68 | 0.012 | |
| compound eye cone cell fate commitment | GO:0042676 | 5 | 0.012 | |
| wing disc morphogenesis | GO:0007472 | 344 | 0.012 | |
| spindle checkpoint | GO:0031577 | 11 | 0.012 | |
| axon midline choice point recognition | GO:0016199 | 26 | 0.012 | |
| macromolecule deacylation | GO:0098732 | 11 | 0.012 | |
| eye photoreceptor cell fate commitment | GO:0042706 | 37 | 0.012 | |
| male gamete generation | GO:0048232 | 201 | 0.012 | |
| taxis | GO:0042330 | 304 | 0.012 | |
| dorsal vessel heart proper cell fate commitment | GO:0035053 | 2 | 0.012 | |
| axonogenesis | GO:0007409 | 290 | 0.012 | |
| ovarian follicle cell development | GO:0030707 | 248 | 0.012 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 39 | 0.012 | |
| epidermis development | GO:0008544 | 65 | 0.012 | |
| histone deacetylation | GO:0016575 | 9 | 0.012 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.012 | |
| negative regulation of protein processing | GO:0010955 | 31 | 0.012 | |
| chemical homeostasis | GO:0048878 | 92 | 0.012 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 47 | 0.011 | |
| embryonic hemopoiesis | GO:0035162 | 26 | 0.011 | |
| regulation of protein localization | GO:0032880 | 76 | 0.011 | Human |
| chromosome organization involved in meiosis | GO:0070192 | 10 | 0.011 | |
| negative regulation of chromatin silencing | GO:0031936 | 9 | 0.011 | |
| negative regulation of protein modification process | GO:0031400 | 29 | 0.011 | |
| retina development in camera type eye | GO:0060041 | 4 | 0.011 | |
| negative regulation of phosphorylation | GO:0042326 | 35 | 0.011 | |
| response to organic cyclic compound | GO:0014070 | 89 | 0.011 | |
| oviposition | GO:0018991 | 19 | 0.011 | Worm |
| mitochondrial membrane organization | GO:0007006 | 3 | 0.011 | |
| wnt signaling pathway | GO:0016055 | 98 | 0.011 | |
| genitalia development | GO:0048806 | 26 | 0.011 | |
| cytoplasmic transport | GO:0016482 | 130 | 0.011 | |
| regulation of striated muscle contraction | GO:0006942 | 2 | 0.010 | |
| ecdysone mediated induction of salivary gland cell autophagic cell death | GO:0035072 | 12 | 0.010 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 39 | 0.010 | |
| negative regulation of histone methylation | GO:0031061 | 3 | 0.010 | |
| response to endogenous stimulus | GO:0009719 | 119 | 0.010 | |
| phagocytosis | GO:0006909 | 215 | 0.010 | |
| establishment of ommatidial planar polarity | GO:0042067 | 49 | 0.010 | |
| protein phosphorylation | GO:0006468 | 169 | 0.010 | |
| regulation of nucleoside metabolic process | GO:0009118 | 50 | 0.010 | |
| phosphorylation | GO:0016310 | 294 | 0.010 | |
| cellular amine metabolic process | GO:0044106 | 12 | 0.010 | |
| protein catabolic process | GO:0030163 | 101 | 0.010 | |